Showing results (501-510 of 566) with videos related to
Sort By:
Pageof 57
Plos One|August 10, 2017
Maternal exposure to an environmentally relevant dose of triclocarban results in perinatal exposure and potential alterations in offspring development in the mouse modelHeather A Enright, Miranda J S Falso, Michael A Malfatti, et al.Cancer|June 16, 2016
Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiationCameron W Swanick, Xiudong Lei, Simona F Shaitelman, et al.The Oncologist|December 8, 2011
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancerJing Li, Ana M Gonzalez-Angulo, Pamela K Allen, et al.International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapyThomas A Buchholz, Eugene H Huang, Donald Berry, et al.International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapyAmit K Garg, Eric A Strom, Marsha D McNeese, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiationThomas A Buchholz, Susan L Tucker, Lawrence Masullo, et al.Circulation Research|November 20, 2010
Myocyte turnover in the aging human heartJan Kajstura, Narasimman Gurusamy, Barbara Ogórek, et al.Annals of Surgical Oncology|July 14, 2000
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancerF Meric, N Q Mirza, A U Buzdar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conferenceThomas A Buchholz, Constance D Lehman, Jay R Harris, et al.Annals of Surgical Oncology|March 30, 2002
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapyNadeem Q Mirza, Georges Vlastos, Funda Meric, et al.Pageof 57